AMRX — Amneal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSuper Stock

Annual balance sheet for Amneal Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	151	341	248	26	91.5
Net Total Accounts Receivable
Net Total Receivables	636	674	728	797	646
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,210	1,552	1,520	1,412	1,378
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	620	605	639	589	550
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	3,666	4,006	3,940	3,799	3,473
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	550	677	677	753	847
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3,434	3,703	3,579	3,501	3,453
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	232	303	360	298	19.8
Total Liabilities & Shareholders' Equity	3,666	4,006	3,940	3,799	3,473
Total Common Shares Outstanding
Total Preferred Shares Outstanding